ClinicalTrials.gg
RecruitingNCT07232511Updated May 4, 2026

Exercise-induced Hypoalgesia Effects of Blood Flow Restriction in People With Rotator Cuff-related Shoulder Pain

An interventional study of Resistance exercise with low AOP and Resistance exercise with moderate BFR in Rotator Cuff Related Shoulder Pain, sponsored by University of Valencia. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by University of Valencia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Motor Activity by University of Valencia — 14 open to participants now, 15 under way, none of them phase 3. Motor Activity · University of Valencia.

Planned enrollment
20th of 22
30 · median 61
Started
2026
with 7 others
No phase
22 of 25
11 open now
Primary completion
2026-12
later than 6 of 14 live
Registered
16th of 25
by date

Among the 25 studies in Motor Activity by University of Valencia, this one is the 20th largest by planned enrollment of the 22 interventional ones that give a count, is one of 8 that started in 2026, is one of 22 with no phase, reaches primary completion later than 6 of the 14 other live ones, and was the 16th registered.

Motor Activity

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

Browse Motor Activity studies →

Open to participants now

14 of the 25 studies in Motor Activity by University of Valencia are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Motor Activity by University of Valencia, or all of them as a file.
02

Study summary

This study aims to compare the effects of blood flow restricted (BFR) exercise and to examine the differences between various BFR protocols on acute pain reduction in individuals with rotator cuff-related shoulder pain, as well as the exercise tolerance at each intensity and occlusion setting. There are four exercise modalities corresponding to different combinations of intensity (%RM) and percentage of occlusion (%AOP): 1) 30% RM and 30% AOP; 2) 30% RM and 50% AOP; 3) 30% RM and 70% AOP; 4) 30% RM and BFR placebo (cuff without pressure).

All participants will complete one session of each of the four exercise modalities, analyzing the variables studied in each for subsequent analysis and comparison.

03

Conditions studied

  • Rotator Cuff Related Shoulder Pain

Browse trials for

Keywords

  • blood flow restriction
  • exercise
  • rotator cuff-related shoulder pain
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65
  • Shoulder symptoms lasting at least 3 months
  • Pain in the proximal anterolateral aspect of the shoulder, aggravated by abduction
  • At least two of the following tests positive: Jobe test, resisted external rotation test, Hawkins-Kennedy test, Neer test, painful arc between 60 and 120 degrees of shoulder abduction

Exclusion criteria

Exclusion Criteria:

  • History of shoulder trauma or surgery
  • Pain of such intensity that it is impossible to perform the proposed exercises
  • Active arm elevation less than 90 degrees
  • Clinical signs of a complete tear (positive delayed external and internal rotation sign and positive arm drop test)
  • Suspected frozen shoulder (50% reduction or more than 30° loss in passive shoulder external rotation)
  • Primary diagnosis of shoulder instability or acromioclavicular pathology
  • Shoulder pain due to primary involvement in the cervical or thoracic region
  • injections in the last 6 weeks
  • Presence of diseases such as inflammatory arthritis, neurological diseases, fibromyalgia, malignant tumors, or polymyalgia rheumatica
  • Presence of more than one risk factor for thromboembolism
  • Participation in upper limb exercise programs in the last month
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Resistance exercise with low blood occlusion

    A single session of exercise, 30% repetition maximum, and 30% blood occlusion

    Device: Resistance exercise with low AOP

  • Experimental
    Resistance exercise with moderate blood occlusion

    A single session of exercise, 30% repetition maximum, and 50% blood occlusion

    Device: Resistance exercise with moderate BFR

  • Experimental
    Resistance exercise with high blood occlusion

    A single session of exercise, 30% repetition maximum, and 70% blood occlusion

    Device: Resistance exercise with high BFR

  • Sham comparator
    Resistance exercise with sham blood flow restriction

    A single session of exercise, 30% repetition maximum, and without blood restriction (cuff applied without pressure)

    Device: Resistance exercise with sham BFR

Interventions

  • DeviceResistance exercise with low AOP

    Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 30% RM and a 30% of arterial occlusion pressure. 30" rest between sets, 2' rest between exercises.

  • DeviceResistance exercise with moderate BFR

    Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 30% RM and a 50% of arterial occlusion pressure. 30" rest between sets, 2' rest between exercises.

  • DeviceResistance exercise with high BFR

    Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 30% RM and a 70% of arterial occlusion pressure. 30" rest between sets, 2' rest between exercises.

  • DeviceResistance exercise with sham BFR

    Three exercises: external rotation at 0°, internal rotation at 0° and elevation in the scapular plane. 4 sets (30, 15, 15, reps to fatigue) with a intensity of 30% RM and a sham blood flow restriction application (cuff applied without pressure). 30" rest between sets, 2' rest between exercises.

06

What researchers measure

Primary outcomes

  1. Pain intensity at rest (Visual Analogue Scale, 0-10)

    Pain intensity perceived on a Visual Analogue Scale, at rest, being 0 no pain and 10 the worst pain imaginable.

    Time frame: Periprocedural

  2. Pain intensity during movement (Visual Analogue Scale, 0-10)

    Pain intensity perceived on a Visual Analogue Scale during movement (flexion and abduction movement without load), being 0 no pain and 10 the worst pain imaginable

    Time frame: Periprocedural

Secondary outcomes

  1. Pressure pain threshold

    Pressure pain threshold measured in the middle deltoid (peripheral sensitivity) and tibialis anterior (central sensitivity), using an algometer

    Time frame: Periprocedural

  2. Exercise tolerance with each setting

    Exercise tolerance with each setting according to the following 5-point scale: well tolerated, tolerated, neutral, poorly tolerated, not tolerated.

    Time frame: Periprocedural

  3. Occurrence of adverse effects

    Occurrence of adverse effects (e.g., pain, delayed onset muscle soreness, sudden weakness of the trained limb, redness or swelling of the trained limb, etc.) by self-report.

    Time frame: Immediately after the intervention, 1 hour, 6 hours, 24 hours

  4. Surface electromyography

    Surface electromyography for the study of muscle recruitment (middle deltoid, infraspinatus, teres minor and trapezius muscles)

    Time frame: Periprocedural

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — The data that support the findings of this study will be available from the corresponding author upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 9 months is below that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2025
First posted
Nov 18, 2025
StartActual
Mar 5, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07232511
Responsible party
Adrián Escriche Escuder (PhD, University of Valencia) — Principal investigator
First posted
Nov 18, 2025
Start date
Mar 5, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 4, 2026

Study contacts

Adrian Escriche-Escuder, PhD
Contact
adrian.escriche@uv.es
+34 963 98 38 55
Adrian Escriche-Escuder, PhD
principal investigator · University of Valencia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion